Question · from the living review of Type 2 Diabetes Management →

Is it true that very-low-calorie diets (≤800 kcal/day for 8 or more weeks) achieve type 2 diabetes remission in a clinically meaningful proportion of people with short diabetes duration and overweight or obesity?

Uncertain updated weekly · as of

Priors rates this Uncertain — 50 out of 100, updated weekly. It is genuinely uncertain. On the claim that very-low-calorie diets (≤800 kcal/day for 8 or more weeks) achieve type 2 diabetes remission in a clinically meaningful proportion of people with short diabetes duration and overweight or obesity, its four-agent AI review panel weighs 15 primary peer-reviewed studies.

RefutedDoubtfulUncertainLikelyEstablished
where this sits on Priors’ scale of how settled the evidence is

How we got this answer. Priors runs each claim through a panel of four AI agents, each acting as a specialist expert reviewer. They read the published, peer-reviewed studies behind the question, judge how strong, consistent and reliable the evidence is, and turn that judgment into a single rating from 0 to 100 — refreshed every week as new studies appear, so it reflects where the evidence stands today, not a one-off verdict.

The traceable studies behind this rating — and the panel’s single strongest counter-argument to it — are in Priors’ full Type 2 Diabetes Management review.

Related Metabolic & Endocrine questions

Is it true that GLP-1 receptor agonists have significantly lower rates of hypoglycaemia than sulphonylureas when used as monotherapy or add-on to metformin? → Is it true that empagliflozin reduces cardiovascular mortality in people with type 2 diabetes and established cardiovascular disease (EMPA-REG OUTCOME evidence)? → Is it true that tirzepatide achieves superior HbA1c reduction compared with injectable semaglutide 1 mg weekly in people with type 2 diabetes (SURPASS-2 evidence)? → Is it true that liraglutide reduces the risk of major adverse cardiovascular events in people with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors (LEADER trial evidence)? →
Reflects the peer-reviewed evidence as of 17 July 2026 and updates as new studies land. AI can make mistakes. Not medical advice.